Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2009 Apr 24

PMID 19386731

Citations 109

Authors

H M Hefzy

W S Bartynski

J F Boardman

D Lacomis

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Hemorrhage is known to occur in posterior reversible encephalopathy syndrome (PRES), but the characteristics have not been analyzed in detail. The purpose of this study was to evaluate the imaging and clinical features of hemorrhage in PRES.

Materials And Methods: Retrospective assessment of 151 patients with PRES was performed, and 23 patients were identified who had intracranial hemorrhage at toxicity. Hemorrhage types were identified and tabulated, including minute focal hemorrhages (<5 mm), sulcal subarachnoid hemorrhage, and focal hematoma. Clinical features of hemorrhage and nonhemorrhage PRES groups were evaluated, including toxicity blood pressure, coagulation profile/platelet counts, coagulation-altering medication, and clinical conditions associated with PRES. Toxicity mean arterial pressure (MAP) groups were defined as normal (<106 mm Hg), mildly hypertensive (106-116 mm Hg), or severely hypertensive (>116 mm Hg).

Results: The overall incidence of hemorrhage was 15.2%, with borderline statistical significance noted between the observed clinical associations (P = .07). Hemorrhage was significantly more common (P = .02) after allogeneic bone marrow transplantation (allo-BMT) than after solid-organ transplantation. The 3 hemorrhage types were noted with equal frequency. A single hemorrhage type was found in 16 patients, with multiple types noted in 7. Patients undergoing therapeutic anticoagulation were statistically more likely to develop hemorrhage (P = .04). No difference in hemorrhage incidence was found among the 3 blood pressure subgroups (range, 14.9%-15.9%).

Conclusions: Three distinct types of hemorrhage (minute hemorrhage, sulcal subarachnoid hemorrhage, hematoma) were identified in PRES with equal frequency. The greatest hemorrhage frequency was seen after allo-BMT and in patients undergoing therapeutic anticoagulation. Hemorrhage rate was independent of the toxicity blood pressure.

Citing Articles

Late Postpartum Eclampsia with Posterior Reversible Encephalopathy Syndrome and Subarachnoid Hemorrhage: A Case Study.

Elshafei M, Oweis H, Hafez Y, Alom T, Hayani Z, ElNebrisi E Medicina (Kaunas). 2025; 61(1.

PMID: 39859059 PMC: 11767126. DOI: 10.3390/medicina61010077.

Rare association of posterior reversible encephalopathy syndrome (PRES) with hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome - A case report and review of the literature.

Zdraljevic M, Pejovic A, Jocic-Pivac B, Budimkic M, Jovanovic D, Mijajlovic M Heliyon. 2025; 10(24):e40915.

PMID: 39802606 PMC: 11724767. DOI: 10.1016/j.heliyon.2024.e40915.

Magnetic resonance imaging patterns and perfusion changes of posterior reversible encephalopathy syndrome in children with clinical outcome correlation.

Sharma S, Tiwari S, Yadav T, Saini L, Mittal A, Khera D Pediatr Radiol. 2024; 54(11):1884-1895.

PMID: 39249148 DOI: 10.1007/s00247-024-06045-w.

Clinical features and outcomes of posterior reversible encephalopathy syndrome after heart transplantation: a case series.

Lim J, Kim S, Mo C, Kim H, Lee S Clin Transplant Res. 2024; 38(2):154-162.

PMID: 38910457 PMC: 11228383. DOI: 10.4285/ctr.24.0009.

Posterior Reversible Encephalopathy Syndrome With Hemorrhagic Transformation in the Postoperative Period of a Kidney Transplant.

Dehesa-Lopez E, Irizar-Santana S, Valdez-Cruz M, Sosa-Guerrero S, Lopez-Moreno F Cureus. 2024; 16(3):e55584.

PMID: 38576656 PMC: 10993100. DOI: 10.7759/cureus.55584.

References

Hart M, EARLE K . Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry. 1975; 38(6):585-91. PMC: 492033. DOI: 10.1136/jnnp.38.6.585. View

Engelter S, Petrella J, Alberts M, Provenzale J . Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol. 1999; 173(6):1491-3. DOI: 10.2214/ajr.173.6.10584788. View

Casey S, McKinney A, Teksam M, Liu H, Truwit C . CT perfusion imaging in the management of posterior reversible encephalopathy. Neuroradiology. 2004; 46(4):272-6. DOI: 10.1007/s00234-003-1053-6. View

Zimmer W, Hourihane J, Wang H, Schriber J . The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol. 1998; 19(4):601-8; discussion 609-10. PMC: 8337412. View

Rail D, Perkin G . Computerized tomographic appearance of hypertensive encephalopathy. Arch Neurol. 1980; 37(5):310-1. DOI: 10.1001/archneur.1980.00500540088015. View

Bartynski W, Boardman J . Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007; 29(3):447-55. PMC: 8118858. DOI: 10.3174/ajnr.A0839. View

Rabinstein A, Weigand S, Atkinson J, Wijdicks E . Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2005; 36(5):992-7. DOI: 10.1161/01.STR.0000163090.59350.5a. View

Gocmen R, Ozgen B, Karli Oguz K . Widening the spectrum of PRES: series from a tertiary care center. Eur J Radiol. 2007; 62(3):454-9. DOI: 10.1016/j.ejrad.2006.12.001. View

Teal P, Pessin M . Hemorrhagic transformation. The spectrum of ischemia-related brain hemorrhage. Neurosurg Clin N Am. 1992; 3(3):601-10. View

10.

Benigni A, Morigi M, Perico N, Zoja C, Amuchastegui C, Piccinelli A . The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation. 1992; 54(5):775-80. DOI: 10.1097/00007890-199211000-00002. View

11.

Kitaguchi H, Tomimoto H, Miki Y, Yamamoto A, Terada K, Satoi H . A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology. 2005; 47(9):652-6. DOI: 10.1007/s00234-005-1399-z. View

12.

Marsen T, Weber F, Egink G, Suckau G, Baldamus C . Cyclosporin A induces prepro endothelin-1 gene transcription in human endothelial cells. Eur J Pharmacol. 1999; 379(1):97-106. DOI: 10.1016/s0014-2999(99)00447-1. View

13.

Gijtenbeek J, van den Bent M, Vecht C . Cyclosporine neurotoxicity: a review. J Neurol. 1999; 246(5):339-46. DOI: 10.1007/s004150050360. View

14.

Bartynski W, Grabb B, Zeigler Z, Lin L, ANDREWS D . Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr. 1997; 21(6):872-80. DOI: 10.1097/00004728-199711000-00005. View

15.

Bartynski W, Zeigler Z, Shadduck R, Lister J . Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol. 2004; 25(2):261-9. PMC: 7974616. View

16.

Lee H, Chang K, Kim J, Na D, Kwon B, Lee K . Serial MR imaging findings of acute hemorrhagic leukoencephalitis: a case report. AJNR Am J Neuroradiol. 2005; 26(8):1996-9. PMC: 8148839. View

17.

Kon V, Sugiura M, Inagami T, Harvie B, Ichikawa I, Hoover R . Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int. 1990; 37(6):1487-91. DOI: 10.1038/ki.1990.139. View

18.

Tenembaum S, Chamoles N, Fejerman N . Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002; 59(8):1224-31. DOI: 10.1212/wnl.59.8.1224. View

19.

Bartynski W, Boardman J, Zeigler Z, Shadduck R, Lister J . Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006; 27(10):2179-90. PMC: 7977225. View

20.

Ahn K, You W, Jeong S, Lee J, Kim B, Lee J . Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology. 2004; 46(12):978-83. DOI: 10.1007/s00234-004-1276-1. View